2018
DOI: 10.3390/ijms19113437
|View full text |Cite
|
Sign up to set email alerts
|

Selenium-Binding Protein 1 in Human Health and Disease

Abstract: Selenium-binding protein 1 (SBP1) is a highly conserved protein that covalently binds selenium. SBP1 may play important roles in several fundamental physiological functions, including protein degradation, intra-Golgi transport, cell differentiation, cellular motility, redox modulation, and the metabolism of sulfur-containing molecules. SBP1 expression is often reduced in many cancer types compared to the corresponding normal tissues and low levels of SBP1 are frequently associated with poor clinical outcome. I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
64
0
4

Year Published

2020
2020
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(70 citation statements)
references
References 97 publications
(146 reference statements)
2
64
0
4
Order By: Relevance
“…Inversely, overexpression of GPx1 led to decreased levels of SBP1. Intriguingly, SBP1 is progressively lost during the development of many clinical tumors, which may enhance GPx1 activity (48). This observation further complicates the role of GPx1 in different stages of carcinogenesis.…”
Section: Gpx1mentioning
confidence: 99%
“…Inversely, overexpression of GPx1 led to decreased levels of SBP1. Intriguingly, SBP1 is progressively lost during the development of many clinical tumors, which may enhance GPx1 activity (48). This observation further complicates the role of GPx1 in different stages of carcinogenesis.…”
Section: Gpx1mentioning
confidence: 99%
“…Reduced expression of selenium-binding protein 1 (SELENBP1), since first cloned in 1997, has been frequently observed in a variety of solid tumors, and is significantly related to unfavorable clinical outcome in multiple cancer types [23]. However, the evidence concerning the clinical relevance of SELENBP1 in human bladder cancer is lacking.…”
Section: Discussionmentioning
confidence: 99%
“…Thereafter, accumulating evidence has convincingly demonstrated that reduced expression of SELENBP1 is an independent predictive of poor clinical outcome in multiple malignant diseases [13][14][15][16][17][18][20][21][22]. Furthermore, an increasing number of in vitro and in vivo studies has also consistently shown that increasing the levels of SELENBP1 significantly suppresses the malignant characteristics of cancer cells, leading scientific community to the consensus that SELENBP1 may act as a putative tumor suppressor involved in the regulation of cell proliferation, senescence, epithelial-mesenchymal transition, migration and apoptosis [23]. However, the clinical significance of SELENBP1 in human bladder cancer has not yet been characterized in any detail.…”
Section: Introductionmentioning
confidence: 99%
“…The mechanisms by which dietary selenium may affect MM tumor progression have only been partly explored, mostly in cell lines, pointing to the crucial role of redox metabolism [ 54 ]. Although it is well established that low levels of SBP1 are frequently associated with poor clinical outcome [ 55 ], the complexity of selenium metabolism has highlighted the fact that among selenocysteine-containing proteins that are members of the glutathione peroxidase family, SBP1 is the only one for which no catalytic function has been assigned [ 56 ]. Therefore, many aspects of this research field require further investigation.…”
Section: Discussionmentioning
confidence: 99%